重症监护中的肺科医生 - 第9部分：急性呼吸窘迫综合征的非通气策略
The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.
作者信息
Cranshaw J, Griffiths M J D, Evans T W
机构信息
Unit of Critical Care, NHLI Division, Imperial College of Science, Technology & Medicine and Royal Brompton Hospital, London SW3 6NP, UK.
出版信息
Thorax. 2002 Sep;57(9):823-9. doi: 10.1136/thorax.57.9.823.
Abstract
Pharmacological approaches to the treatment of ARDS are reviewed. Future treatments should be targeted at elements of the pathological process that produce specific clinical problems.
摘要
本文综述了急性呼吸窘迫综合征（ARDS）的药物治疗方法。未来的治疗应针对产生特定临床问题的病理过程中的各个环节。
相似文献
1
The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.重症监护中的肺科医生 - 第9部分：急性呼吸窘迫综合征的非通气策略
Thorax. 2002 Sep;57(9):823-9. doi: 10.1136/thorax.57.9.823.
2
Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?急性呼吸窘迫综合征中吸入一氧化氮和吸入前列环素：有哪些证据？
Crit Care Clin. 2011 Jul;27(3):561-87. doi: 10.1016/j.ccc.2011.05.001.
3
Recent developments in the management of acute respiratory distress syndrome in adults.成人急性呼吸窘迫综合征管理的最新进展
Am J Health Syst Pharm. 2008 Jan 1;65(1):29-36. doi: 10.2146/ajhp060530.
4
Pharmacological therapies for acute respiratory distress syndrome.急性呼吸窘迫综合征的药物治疗。
Curr Opin Crit Care. 2014 Feb;20(1):113-21. doi: 10.1097/MCC.0000000000000056.
5
Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome.治疗急性肺损伤和急性呼吸窘迫综合征的新兴疗法。
Expert Opin Emerg Drugs. 2007 Sep;12(3):461-77. doi: 10.1517/14728214.12.3.461.
6
Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.吸入依前列醇与吸入一氧化氮治疗急性呼吸窘迫综合征的非劣效性
Ann Pharmacother. 2015 Oct;49(10):1105-12. doi: 10.1177/1060028015595642. Epub 2015 Jul 17.
7
Therapeutic approach in early and late ARDS.早期和晚期急性呼吸窘迫综合征的治疗方法。
Acta Anaesthesiol Scand Suppl. 1997;110:48-51. doi: 10.1111/j.1399-6576.1997.tb05497.x.
8
Supportive pharmacotherapy for patients with acute respiratory distress syndrome.急性呼吸窘迫综合征患者的支持性药物治疗
Acta Anaesthesiol Scand Suppl. 1996;109:65-9.
9
Inhaled nitric oxide in ARDS: modulator of lung injury?
Intensive Care Med. 1999 Sep;25(9):1024-6. doi: 10.1007/s001340051002.
10
Acute respiratory distress syndrome. Potential pharmacologic interventions.急性呼吸窘迫综合征。潜在的药物干预措施。
Clin Chest Med. 2000 Sep;21(3):563-87. doi: 10.1016/s0272-5231(05)70167-2.
引用本文的文献
1
Prone position for acute respiratory failure in adults.成人急性呼吸衰竭的俯卧位
Cochrane Database Syst Rev. 2015 Nov 13;2015(11):CD008095. doi: 10.1002/14651858.CD008095.pub2.
2
Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis.一氧化氮对急性肺损伤患者氧合及死亡率的影响：系统评价与荟萃分析
BMJ. 2007 Apr 14;334(7597):779. doi: 10.1136/bmj.39139.716794.55. Epub 2007 Mar 23.
3
Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis.外源性肺表面活性物质治疗成人急性呼吸窘迫综合征：一项荟萃分析的结果
Crit Care. 2006;10(2):R41. doi: 10.1186/cc4851.
4
Endothelin antagonists: new bullets against lung injury?内皮素拮抗剂：对抗肺损伤的新型武器？
Crit Care. 2005 Jun;9(3):245-6. doi: 10.1186/cc3525. Epub 2005 Apr 14.
5
Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.针对成人急性肺损伤和急性呼吸窘迫综合征的药物治疗
Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004477. doi: 10.1002/14651858.CD004477.pub2.
6
Acute lung injury and acute respiratory distress syndrome.急性肺损伤和急性呼吸窘迫综合征
Indian J Pediatr. 2004 Aug;71(8):743-50. doi: 10.1007/BF02730667.
7
The pulmonary physician in critical care * Illustrative case 6: Acute chest syndrome of sickle cell anaemia.重症监护领域的肺科医生 * 示例病例6：镰状细胞贫血急性胸综合征
Thorax. 2003 Aug;58(8):726-8. doi: 10.1136/thorax.58.8.726.
本文引用的文献
1
Efficacy and safety of recombinant human activated protein C for severe sepsis.重组人活化蛋白C治疗严重脓毒症的疗效与安全性
N Engl J Med. 2001 Mar 8;344(10):699-709. doi: 10.1056/NEJM200103083441001.
2
Inhaled nitric oxide and acute lung injury.
Clin Chest Med. 2000 Sep;21(3):519-29, ix. doi: 10.1016/s0272-5231(05)70163-5.
3
Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock.脓毒症和脓毒性休克中的急性肺损伤与急性呼吸窘迫综合征
Crit Care Clin. 2000 Apr;16(2):289-317. doi: 10.1016/s0749-0704(05)70111-1.
4
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.肺纤维化中基因表达的全局分析揭示了调节肺部炎症和纤维化的不同程序。
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1778-83. doi: 10.1073/pnas.97.4.1778.
5
Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome.N-乙酰半胱氨酸和芦丁对成人呼吸窘迫综合征期间肺上皮细胞脂质过氧化的保护作用。
Shock. 2000 Jan;13(1):14-8. doi: 10.1097/00024382-200013010-00003.
6
Immunonutrition in the critically ill: a systematic review of clinical outcome.危重症患者的免疫营养：临床结局的系统评价
Crit Care Med. 1999 Dec;27(12):2799-805. doi: 10.1097/00003246-199912000-00032.
7
Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome.
Am J Respir Crit Care Med. 1999 Oct;160(4):1188-95. doi: 10.1164/ajrccm.160.4.9808118.
8
Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide.急性肺损伤中吸入一氧化氮：一项欧洲多中心研究的结果。欧洲吸入一氧化氮研究小组。
Intensive Care Med. 1999 Sep;25(9):911-9. doi: 10.1007/s001340050982.
9
Dietary lipids: ancestral ligands and regulators of cell signaling pathways.
Crit Care Med. 1999 Aug;27(8):1646-8. doi: 10.1097/00003246-199908000-00047.
10
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.脂质体前列腺素E1（TLC C-53）治疗急性呼吸窘迫综合征：一项对照、随机、双盲、多中心临床试验。TLC C-53急性呼吸窘迫综合征研究组
Crit Care Med. 1999 Aug;27(8):1478-85. doi: 10.1097/00003246-199908000-00013.
Zotero 插件